
Celiac Disease Global Market Report 2025
Description
Celiac Disease Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on celiac disease market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Where is the largest and fastest growing market for celiac disease ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The celiac disease market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
Markets Covered:1) By Treatment: Infliximab; Larazotide Acetate; Gluten Free Diet; Other Treatments
2) By Route Of Administration: Oral; Parenteral
3) By End Users: Hospitals; Homecare; Other End-Users
Subsegments:
1) By Infliximab: Biosimilar Infliximab; Branded Infliximab; Intravenous Administration; Hospital-Based Usage; Off-Label Use In Refractory Celiac Disease;
2) By Larazotide Acetate: Clinical Trial Phase Products; Oral Capsule Formulation; Adult Celiac Patients; Pediatric Investigational Use; Monotherapy And Combination Therapy
3) By Gluten Free Diet: Packaged Gluten-Free Foods; Gluten-Free Bakery Products; Gluten-Free Snacks; Gluten-Free Nutritional Supplements; Gluten-Free Beverages
4) By Other Treatments: Corticosteroids; Immunosuppressive Drugs; Enzyme Therapies; Monoclonal Antibodies; Probiotics And Microbiome Modulators
Companies Mentioned: Pfizer Inc.; Sanofi SA; Novartis AG; Takeda Pharmaceutical Company Ltd.; Chugai Pharmaceutical Co. Ltd.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
This report focuses on celiac disease market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for celiac disease ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The celiac disease market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Markets Covered:1) By Treatment: Infliximab; Larazotide Acetate; Gluten Free Diet; Other Treatments
2) By Route Of Administration: Oral; Parenteral
3) By End Users: Hospitals; Homecare; Other End-Users
Subsegments:
1) By Infliximab: Biosimilar Infliximab; Branded Infliximab; Intravenous Administration; Hospital-Based Usage; Off-Label Use In Refractory Celiac Disease;
2) By Larazotide Acetate: Clinical Trial Phase Products; Oral Capsule Formulation; Adult Celiac Patients; Pediatric Investigational Use; Monotherapy And Combination Therapy
3) By Gluten Free Diet: Packaged Gluten-Free Foods; Gluten-Free Bakery Products; Gluten-Free Snacks; Gluten-Free Nutritional Supplements; Gluten-Free Beverages
4) By Other Treatments: Corticosteroids; Immunosuppressive Drugs; Enzyme Therapies; Monoclonal Antibodies; Probiotics And Microbiome Modulators
Companies Mentioned: Pfizer Inc.; Sanofi SA; Novartis AG; Takeda Pharmaceutical Company Ltd.; Chugai Pharmaceutical Co. Ltd.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Table of Contents
175 Pages
- 1. Executive Summary
- 2. Celiac Disease Market Characteristics
- 3. Celiac Disease Market Trends And Strategies
- 4. Celiac Disease Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
- 5. Global Celiac Disease Growth Analysis And Strategic Analysis Framework
- 5.1. Global Celiac Disease PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Celiac Disease Market Growth Rate Analysis
- 5.4. Global Celiac Disease Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Celiac Disease Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Celiac Disease Total Addressable Market (TAM)
- 6. Celiac Disease Market Segmentation
- 6.1. Global Celiac Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Infliximab
- Larazotide Acetate
- Gluten Free Diet
- Other Treatments
- 6.2. Global Celiac Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Oral
- Parenteral
- 6.3. Global Celiac Disease Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals
- Homecare
- Other End-Users
- 6.4. Global Celiac Disease Market, Sub-Segmentation Of Infliximab, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Biosimilar Infliximab
- Branded Infliximab
- Intravenous Administration
- Hospital-Based Usage
- 6.5. Global Celiac Disease Market, Sub-Segmentation Off-Label Use In Refractory Celiac Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Of Larazotide Acetate, By Type
- Clinical Trial Phase Products
- Oral Capsule Formulation
- Adult Celiac Patients
- Pediatric Investigational Use
- Monotherapy and Combination Therapy
- 6.6. Global Celiac Disease Market, Sub-Segmentation Of Gluten Free Diet, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Packaged Gluten-Free Foods
- Gluten-Free Bakery Products
- Gluten-Free Snacks
- Gluten-Free Nutritional Supplements
- Gluten-Free Beverages
- 6.7. Global Celiac Disease Market, Sub-Segmentation Of Other Treatments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Corticosteroids
- Immunosuppressive Drugs
- Enzyme Therapies
- Monoclonal Antibodies
- Probiotics And Microbiome Modulators
- 7. Celiac Disease Market Regional And Country Analysis
- 7.1. Global Celiac Disease Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Celiac Disease Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8. Asia-Pacific Celiac Disease Market
- 8.1. Asia-Pacific Celiac Disease Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Celiac Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Celiac Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Celiac Disease Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 9. China Celiac Disease Market
- 9.1. China Celiac Disease Market Overview
- 9.2. China Celiac Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Celiac Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Celiac Disease Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 10. India Celiac Disease Market
- 10.1. India Celiac Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Celiac Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Celiac Disease Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11. Japan Celiac Disease Market
- 11.1. Japan Celiac Disease Market Overview
- 11.2. Japan Celiac Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Celiac Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Celiac Disease Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12. Australia Celiac Disease Market
- 12.1. Australia Celiac Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Celiac Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Celiac Disease Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13. Indonesia Celiac Disease Market
- 13.1. Indonesia Celiac Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Celiac Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Celiac Disease Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14. South Korea Celiac Disease Market
- 14.1. South Korea Celiac Disease Market Overview
- 14.2. South Korea Celiac Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Celiac Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Celiac Disease Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15. Western Europe Celiac Disease Market
- 15.1. Western Europe Celiac Disease Market Overview
- 15.2. Western Europe Celiac Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Celiac Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Celiac Disease Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16. UK Celiac Disease Market
- 16.1. UK Celiac Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Celiac Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Celiac Disease Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17. Germany Celiac Disease Market
- 17.1. Germany Celiac Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Celiac Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Celiac Disease Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18. France Celiac Disease Market
- 18.1. France Celiac Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Celiac Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Celiac Disease Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19. Italy Celiac Disease Market
- 19.1. Italy Celiac Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Celiac Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Celiac Disease Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20. Spain Celiac Disease Market
- 20.1. Spain Celiac Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Celiac Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Celiac Disease Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21. Eastern Europe Celiac Disease Market
- 21.1. Eastern Europe Celiac Disease Market Overview
- 21.2. Eastern Europe Celiac Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Celiac Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Celiac Disease Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22. Russia Celiac Disease Market
- 22.1. Russia Celiac Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Celiac Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Celiac Disease Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23. North America Celiac Disease Market
- 23.1. North America Celiac Disease Market Overview
- 23.2. North America Celiac Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Celiac Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Celiac Disease Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24. USA Celiac Disease Market
- 24.1. USA Celiac Disease Market Overview
- 24.2. USA Celiac Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Celiac Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Celiac Disease Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25. Canada Celiac Disease Market
- 25.1. Canada Celiac Disease Market Overview
- 25.2. Canada Celiac Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Celiac Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Celiac Disease Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26. South America Celiac Disease Market
- 26.1. South America Celiac Disease Market Overview
- 26.2. South America Celiac Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Celiac Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Celiac Disease Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27. Brazil Celiac Disease Market
- 27.1. Brazil Celiac Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Celiac Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Celiac Disease Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28. Middle East Celiac Disease Market
- 28.1. Middle East Celiac Disease Market Overview
- 28.2. Middle East Celiac Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Celiac Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Celiac Disease Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29. Africa Celiac Disease Market
- 29.1. Africa Celiac Disease Market Overview
- 29.2. Africa Celiac Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Celiac Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Celiac Disease Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 30. Celiac Disease Market Competitive Landscape And Company Profiles
- 30.1. Celiac Disease Market Competitive Landscape
- 30.2. Celiac Disease Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Takeda Pharmaceutical Company Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Chugai Pharmaceutical Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 31. Celiac Disease Market Other Major And Innovative Companies
- 31.1. Dr Falk Pharma GmbH
- 31.2. Theriva Biologics Inc.
- 31.3. Equillium Inc.
- 31.4. Immunic Inc.
- 31.5. Barinthus Biotherapeutics Plc
- 31.6. Allero Therapeutics
- 31.7. Anokion SA
- 31.8. Mozart Therapeutics
- 31.9. ImmunogenX
- 31.10. Topas Therapeutics GmbH
- 31.11. Parvus Therapeutics Inc.
- 31.12. AMYRA Biotech AG
- 31.13. Provention Limited
- 31.14. Precigen Inc.
- 31.15. Zedira GmbH
- 32. Global Celiac Disease Market Competitive Benchmarking And Dashboard
- 33. Key Mergers And Acquisitions In The Celiac Disease Market
- 34. Recent Developments In The Celiac Disease Market
- 35. Celiac Disease Market High Potential Countries, Segments and Strategies
- 35.1 Celiac Disease Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Celiac Disease Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Celiac Disease Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
- 36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.